Jafry Syed A. 4

4 · ZIMMER BIOMET HOLDINGS, INC. · Filed May 16, 2023

Form 4

Period: 2023-05-12

Director

Transactions

Award
Restricted Stock Units
2023-05-12+950.779→ 5,104.937 total
→ Common Stock (950.779 underlying)
Award
Phantom Stock Units
2023-05-12+500→ 4,640.49 total
Exercise: $136.73→ Common Stock (500 underlying)

Footnotes (6)

[F1]The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors.
[F2]The Conversion or Exercise Price of Derivative Security is 1-for-1.
[F3]These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.
[F4]Includes 6.978 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
[F5]The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date.
[F6]Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods.

Documents

1 file